Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The composition of the skin microbiome is predicted to play a role in the development of conditions such as atopic eczema and psoriasis. 16S rRNA gene sequencing allows the investigation of bacterial microbiota. A significant challenge in this field is development of cost effective high throughput methodologies for the robust interrogation of the skin microbiota, where biomass is low. Here we describe validation of methodologies for 16S rRNA (ribosomal ribonucleic acid) gene sequencing from the skin microbiome, using the Illumina MiSeq platform, the selection of primer to amplify regions for sequencing and we compare results with the current standard protocols.. METHODS: DNA was obtained from two low density mock communities of 11 diverse bacterial strains (with and without human DNA supplementation) and from swabs taken from the skin of healthy volunteers. This was amplified using primer pairs covering hypervariable regions of the 16S rRNA gene: primers 63F and 519R (V1-V3); and 347F and 803R (V3-V4). The resultant libraries were indexed for the MiSeq and Roche454 and sequenced. Both data sets were denoised, cleaned of chimeras and analysed using QIIME. RESULTS: There was no significant difference in the diversity indices at the phylum and the genus level observed between the platforms. The capture of diversity using the low density mock community samples demonstrated that the primer pair spanning the V3-V4 hypervariable region had better capture when compared to the primer pair for the V1-V3 region and was robust to spiking with human DNA. The pilot data generated using the V3-V4 region from the skin of healthy volunteers was consistent with these results, even at the genus level (Staphylococcus, Propionibacterium, Corynebacterium, Paracoccus, Micrococcus, Enhydrobacter and Deinococcus identified at similar abundances on both platforms). CONCLUSIONS: The results suggest that the bacterial community diversity captured using the V3-V4 16S rRNA hypervariable region from sequencing using the MiSeq platform is comparable to the Roche454 GS Junior platform. These findings provide evidence that the optimised method can be used in human clinical samples of low bacterial biomass such as the investigation of the skin microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Klindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M., & Glöckner, F. O. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks808 · Cited by 8,850 · cited 1×
“Shorter read lengths are sufficient to analyse microbial communities [11, 31], but limits the ability to maximize the capture of taxonomic diversity; therefore, we used the full capacity of the MiSeq with the 2x 250 bp paired end run (available at the time of the work) to achieve the optimal capture of data.”
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses
Salter, S. J., Cox, M. J., Turek, E. M., Calus, S. T., Cookson, W. O., Moffatt, M. F., Turner, P., Parkhill, J., Loman, N. J., & Walker, A. W. (2014) · BMC Biology · doi:10.1186/s12915-014-0087-z · Cited by 3,463 · cited 4×
“We did not sequence negative controls which are considered as a measure of determining erroneous results [10] due to contamination as there was no detectable product in the samples.”
InfluentialBacterial Community Variation in Human Body Habitats Across Space and Time
Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I., & Knight, R. (2009) · Science · doi:10.1126/science.1177486 · Cited by 3,231 · cited 1×
“In recent years, as a result of initiatives such as the NIH Human microbiome project, the scientific community has made great progress in cataloguing these micro-organisms [2 – 5].”
A framework for human microbiome research
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11209 · Cited by 2,650
Quail, M., Smith, M. E., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., Bertoni, A., Swerdlow, H. P., & Gu, Y. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-341 · Cited by 2,031 · cited 4×
“However, increasingly, microbiome studies are utilising newer NGS platforms, such as the Illumina MiSeq, which have been reported to be more cost effective and accurate, but have shorter read lengths [13, 16].”
InfluentialKong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808 · cited 1×
“The mock community included a known skin commensal, Staphyloccocus species, which have been implicated in skin diseases such as atopic eczema where there is an increase in their abundance [27] and in psoriasis where reduced abundance has been reported [28].”
Martínez, I., Stegen, J. C., Maldonado-Gómez, M. X., Eren, A. M., Siba, P. M., Greenhill, A. R., & Walter, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.049 · Cited by 576 · cited 1×
“This work contributes to the evidence [12, 13, 34, 35] that the MiSeq is a suitable sequencing platform for profiling bacterial communities using analysis of 16S rRNA gene fragments.”
A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters
Huse, S. M., Ye, Y., Zhou, Y., & Fodor, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034242 · Cited by 572 · cited 1×
“The data in the NIH Human Microbiome project [5] was derived from pyrosequencing using the Roche 454 FLX Titanium technology using amplicons generated from V1-V3 and V3-V5 hypervariable regions.”
Chng, K. R., Tay, A. S. L., Li, C., Ng, A. H. Q., Wang, J., Suri, B. K., Matta, S. A., McGovern, N., Janela, B., Wong, X. F. C. C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.106 · Cited by 388
Strong, M. J., Xu, G., Morici, L., Splinter Bon-Durant, S., Baddoo, M., Lin, Z., Fewell, C., Taylor, C. M., & Flemington, E. K. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004437 · Cited by 186 · cited 1×
“There have been studies on the effect of laboratory and reagent contamination in low biomass samples [10], on human-derived RNA-seq datasets [29] and bacterial contamination in human genome sequencing [30].”
Cited by
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806
Challenges in exploring and manipulating the human skin microbiome
Boxberger, M., Cenizo, V., Cassir, N., & La Scola, B. (2021) · Microbiome · doi:10.1186/s40168-021-01062-5 · Cited by 247
Gut Microbiome in Psoriasis: An Updated Review
Sikora, M., Stec, A., Chrabaszcz, M., Knot, A., Waskiel-Burnat, A., Rakowska, A., Olszewska, M., & Rudnicka, L. (2020) · Pathogens · doi:10.3390/pathogens9060463 · Cited by 118
Stehlikova, Z., Kostovcik, M., Kostovcikova, K., Kverka, M., Juzlova, K., Rob, F., Hercogova, J., Bohac, P., Pinto, Y., Uzan, A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00438 · Cited by 105
Metadata
- Authors
- Castelino, M., Eyre, S., Moat, J., Fox, G., Martin, P., Ho, P., Upton, M., & Barton, A.
- Venue
- BMC Microbiology
- Published
- 2017-01-21
- Volume
- 17
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1471-2180 (ISSN-L)
- OpenAlex
- W2578475518
- Cited by
- 154
- References
- 10
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform. https://app.cochat.ai/papers/10.1186/s12866-017-0927-4
- The paper
- Castelino, M., Eyre, S., Moat, J., Fox, G., Martin, P., Ho, P., Upton, M., & Barton, A. (2017). Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform. BMC Microbiology. https://doi.org/10.1186/s12866-017-0927-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.